Increased CSF gamma-aminobutyric acid after treatment with gamma-vinyl GABA.
D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors*; D000614:Aminocaproates / Q000627:therapeutic use*; D001923:Brain Chemistry; D002493:Central Nervous System Diseases / Q000188:drug therapy; D006801:Humans; D000637:Transaminases / Q000037:antagonists & inhibitors*; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid / Q000032:analysis / Q000134:cerebrospinal fluid*
D000614:Aminocaproates; D005680:gamma-Aminobutyric Acid; D000637:Transaminases; D000612:4-Aminobutyrate Transaminase; D020888:Vigabatrin